The treatment of childhood Hodgkin lymphoma: Improved survival in a developing country

Hodgkin Lymphoma in Children

“…[7][8][9][10][11][12][13][14] Reports from Europe and North America have given the mean/median age of presentation of the childhood form of HL as ranging between 12 and 15 years. Boys presented at a statistically significant younger age (7.72 ± 2.4 vs. 9.66 ± 3.1 in girls).…”

“…Studies from India and from other resource-poor nations have observed B symptoms in the range of 37% to 54%. [11][12][13]19 In the pediatric age group, most reports from North America and Europe have shown nodular sclerosis (60% to 70%) as the most frequent subtype. 2,5,12,18 Mixed cellularity was the most common histopathologic subtype (69.6%), followed by nodular sclerosis (10.1%).…”

Risks and diagnosis of coronary artery disease in Hodgkin lymphoma survivors

“…With advanced diagnostic and therapeutic facilities the survival rates in low and high risk patients with HL increased to 95% and 90% respectively [33,34] . Similarly, improved results after HL treatment were also published in articles from Turkey in recent years [35,36] . To diagnose earlier and proper treatment of long-term unwanted effects have become one of the main issues in practice of both Pediatric and Medical Oncology parallel to the good results taken in cancer treatment.…”

“…To diagnose earlier and proper treatment of long-term unwanted effects have become one of the main issues in practice of both Pediatric and Medical Oncology parallel to the good results taken in cancer treatment. The frequency of cardiovascular disease peaks generally five to ten years after the completion of HL treatment [35,36] .…”

Çocukluk çağı Hodgkin lenfoma hastalarının uzun dönem izlemlerinde kalp işlevlerinin doku Doppler ekokardiyografi yöntemi ile değerlendirilmesi

“…Marked advances have been observed in treatment of pediatric Hodgkin lymphoma disease in recent years in developing countries (1). However, side effects related to the medications and radiotherapy used for the primary disease constitute an important problem.…”